|
Cathy McDermott is our Vice President of Regulatory and Clinical Affairs. She has extensive experience in drug development in the areas of Regulatory, Quality, and Clinical. She has been responsible for regulatory strategic drug development worldwide in the areas of HIV, Oncology, Cardiology, Cell Therapy, Therapeutic Biologics, Neurology, and Vaccines. She has successfully filed several NDAs and BLAs with the US Food and Drug Administration. She has worked in several pharmaceutical companies, contract research organizations, and most recently as an independent consultant. She earned BS degrees in Biology and Nursing from Georgetown University in 1984, and a Masters in Public Health from Johns Hopkins University in 1995. | 